Drug Eluting Balloons and Hemodialysis Access Preservation
Maintaining functional access for hemodialysis is vital for patients with kidney failure. Access sites, particularly arteriovenous fistulas, are prone to stenosis due to repeated needle punctures and turbulent blood flow. Drug eluting balloons are increasingly used to manage these blockages effectively.
DEBs deliver anti-proliferative medication that slows down the tissue growth responsible for restenosis. This can significantly extend the lifespan of dialysis access points and reduce the frequency of repeat interventions.
The procedure is fast, safe, and minimally invasive. By avoiding permanent implants, DEBs help preserve the natural structure of the access site, making future repairs easier. Their effectiveness is particularly valuable in patients with recurrent stenosis.
As the demand for long-term dialysis treatment rises, DEBs provide a reliable option for sustaining vascular access durability.
FAQs
1. Are DEBs safe for dialysis patients?
Yes, they are widely used and well-tolerated.
2. Will the balloon interfere with frequent needle use?
No permanent device remains, so access function is preserved.
3. How long do results last?
Duration varies, but DEBs often prolong patency compared to plain balloons.